RYE BROOK, N.Y.–(BUSINESS WIRE)–Jan. 27, 2022– Xylem (NYSE:XYL), a leading global water technology company, has today announced that it received a score of 100 on the Human Rights Campaign Foundation’s 2022 Corporate Equality Index. This is the third year in a row that Xylem has earned top marks on the U.S. benchmarking survey which measures... Read more
Two papers in The Lancet highlight one-year results from Roche’s phase III trials evaluating faricimab in neovascular or “wet” age-related macular (nAMD) and diabetic macular edema (DME) Across four studies, about half of eligible faricimab patients were able to go four months between treatments, and approximately three-quarters could be treated every three months or longer... Read more
Notice Concerning Recording of Extraordinary Gains and Losses Related to Subsidization | IR News | News Release ＆ IR News | Investor Relations Read more
RYE BROOK, N.Y.–(BUSINESS WIRE)–Jan. 20, 2022– Global water technology company, Xylem (NYSE:XYL), announced today that almost 80 percent of its 16,000 employees volunteered their time to help solve urgent water challenges in 2021. Xylem’s global team collectively donated 113,000 hours in their communities, across 55 countries. The commitment of volunteer hours doubled from 2020 to... Read more
[Delayed] Corporate Governance Report | IR News | News Release ＆ IR News | Investor Relations Read more
Circulating tumor cells (CTCs) are cells that have broken away from a primary tumor and entered the circulatory system. They can initiate new tumors (metastases) that are the driving factor for the vast majority of cancer-related deaths. Biopharma researchers, cancer researchers and oncologists have focused on the detection and analyses of CTCs to monitor drug... Read more
ANDOVER, Mass., Jan. 10, 2022 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI) (“MKS”), a global provider of technologies that enable advanced processes and improve productivity, today announced that it has withdrawn from exhibiting at Photonics West 2022 in San Francisco. Read more
The above image displaying ribosomal biogenesis and blood vessels in developing zebrafish embryos was awarded first prize in the life sciences category of the LMA/VIA 2021 Image Competition (sponsored by ZEISS) of the Australian Microscopy & Microanalysis Society. Dr. Kazuhide Shaun Okuda, Postdoctoral Fellow at the Hogan laboratory, Peter MacCallum Cancer Centre in Victoria, Australia, took... Read more